SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

GUIDOBONI, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.728
AS - Asia 2.411
EU - Europa 902
SA - Sud America 376
Continente sconosciuto - Info sul continente non disponibili 147
AF - Africa 67
OC - Oceania 4
Totale 6.635
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.585
SG - Singapore 965
CN - Cina 425
IT - Italia 402
BD - Bangladesh 281
BR - Brasile 271
VN - Vietnam 239
HK - Hong Kong 214
FI - Finlandia 96
DE - Germania 89
CA - Canada 68
IN - India 64
GB - Regno Unito 57
FR - Francia 52
ID - Indonesia 51
UA - Ucraina 48
MX - Messico 46
RU - Federazione Russa 42
AR - Argentina 40
JP - Giappone 39
ZA - Sudafrica 28
NL - Olanda 22
EC - Ecuador 20
IQ - Iraq 20
AT - Austria 17
TR - Turchia 17
PH - Filippine 16
PL - Polonia 16
CO - Colombia 14
ES - Italia 12
SE - Svezia 12
MA - Marocco 9
VE - Venezuela 9
KE - Kenya 8
LT - Lituania 8
PK - Pakistan 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
MY - Malesia 7
PY - Paraguay 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
CR - Costa Rica 6
JO - Giordania 6
EG - Egitto 5
HN - Honduras 5
NP - Nepal 5
BA - Bosnia-Erzegovina 4
CH - Svizzera 4
IL - Israele 4
PS - Palestinian Territory 4
UY - Uruguay 4
AU - Australia 3
GR - Grecia 3
JM - Giamaica 3
KG - Kirghizistan 3
PE - Perù 3
RS - Serbia 3
TN - Tunisia 3
AL - Albania 2
BE - Belgio 2
BH - Bahrain 2
BO - Bolivia 2
BS - Bahamas 2
CI - Costa d'Avorio 2
DZ - Algeria 2
ET - Etiopia 2
GE - Georgia 2
IE - Irlanda 2
KH - Cambogia 2
KZ - Kazakistan 2
MN - Mongolia 2
NI - Nicaragua 2
PA - Panama 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GN - Guinea 1
GP - Guadalupe 1
GT - Guatemala 1
HU - Ungheria 1
KI - Kiribati 1
KY - Cayman, isole 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MU - Mauritius 1
MV - Maldive 1
NG - Nigeria 1
Totale 6.479
Salva come PNG Salva come JPEG
Città #
Singapore 579
San Jose 477
Ashburn 361
Santa Clara 311
Hong Kong 210
Council Bluffs 184
Beijing 120
Ho Chi Minh City 87
Los Angeles 86
Helsinki 85
New York 76
Milan 58
Hanoi 53
Houston 50
Dallas 43
Chicago 40
Jakarta 40
Tokyo 39
Woodbridge 37
Fairfield 36
Jacksonville 31
São Paulo 29
Lauterbourg 28
Mexico City 28
Rome 28
Bologna 27
Toronto 26
Ferrara 25
Buffalo 23
Nuremberg 23
Orem 23
Hefei 22
Shanghai 22
Dearborn 17
London 17
Seattle 16
Atlanta 15
Brooklyn 14
Figino 14
Warsaw 14
Phoenix 13
Baghdad 12
Da Nang 12
Frankfurt am Main 12
Naples 12
San Francisco 12
Chennai 11
Johannesburg 11
Montreal 11
Portland 11
Wilmington 11
Cambridge 10
Chandler 10
Falkenstein 10
Haiphong 9
Curitiba 8
Newark 8
Rio de Janeiro 8
Avon 7
Boardman 7
Denver 7
Guangzhou 7
Manchester 7
Mumbai 7
Tashkent 7
The Dalles 7
Vienna 7
Amsterdam 6
Boston 6
Guayaquil 6
Hải Dương 6
Izmir 6
Nanjing 6
Philadelphia 6
Quito 6
Salt Lake City 6
San Diego 6
Stockholm 6
Amman 5
Biên Hòa 5
Charlotte 5
Guarulhos 5
Lappeenranta 5
Manila 5
Nairobi 5
Nanchang 5
New Delhi 5
Parma 5
Poplar 5
Princeton 5
Turin 5
Ann Arbor 4
Assago 4
Asunción 4
Bari 4
Belo Horizonte 4
Bogotá 4
Brescia 4
Cleveland 4
Florence 4
Totale 3.835
Salva come PNG Salva come JPEG
Nome #
The long-term prognostic impact of sentinel lymph node biopsy in patients with primary cutaneous melanoma: a prospective study with 10-year follow-up 206
ML Models Built Using Clinical Parameters and Radiomic Features Extracted from 18F-Choline PET/CT for the Prediction of Biochemical Recurrence after Metastasis-Directed Therapy in Patients with Oligometastatic Prostate Cancer 182
Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis 175
Effect of vaccination with autologous tumor-loaded dendritic cells on intratumoral regulatory T cells in metastatic melanoma patients 162
Near-Complete Response to Osimertinib for Advanced Non-Small-Cell Lung Cancer in a Pretreated Patient Bearing Rare Compound Exon 20 Mutation (S768I + V774M): A Case Report 157
Comparative efficacy and safety of targeted therapies for BRAF-mutant unresectable or metastatic melanoma: Results from a systematic literature review and a network meta-analysis 151
Prognostic value of microsatellite instability and intratumor activated cytotoxic lymphocytes in colon cancer 151
Nectin-4-Targeting Radiotracers: Novel Theranostic Agents for Precision Oncology in Cancer 142
Retinoic acid inhibits the proliferative response induced by CD40 activation and interleukin-4 in mantle cell lymphoma 142
Anti-PD1 antibodies in patients aged ≥ 75 years with metastatic melanoma: A retrospective multicentre study 141
Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated BRAF-Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial 137
Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma 134
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma 124
Efficacy of ipilimumab plus nivolumab or ipilimumab plus fotemustine vs fotemustine in patients with melanoma metastatic to the brain: Primary analysis of the phase III NIBIT-M2 trial 115
Retrospective Chart Review of Dabrafenib Plus Trametinib in Patients with Metastatic BRAF V600-Mutant Melanoma Treated in the Individual Patient Program (DESCRIBE Italy) 107
Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial 105
Cancer Bio-Immunotherapy in Siena": Twelfth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 9-11, 2014 104
Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab 103
Functional up-regulation of human leukocyte antigen class I antigens expression by 5-aza-2'-deoxycytidine in cutaneous melanoma: immunotherapeutic implications 102
Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial 100
Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study 99
Primary Analysis and 4-Year Follow-Up of the Phase III NIBIT-M2 Trial in Melanoma Patients With Brain Metastases 96
Complementary vaccination protocol with dendritic cells pulsed with autologous tumour lysate in patients with resected stage III or IV melanoma: protocol for a phase II randomised trial (ACDC Adjuvant Trial). 96
Outcomes in patients with BRAFV600–mutated melanoma and brain metastases at baseline treated with dabrafenib plus trametinib 90
Combined and sequential expression of p53, Rb, Ras and Bcl-2 in bronchial preneoplastic lesions 90
Association between Helicobacter pylori infection and MALT-type lymphoma of the ocular adnexa: clinical and therapeutic implications 90
Stability Program in Dendritic Cell Vaccines: A “Real-World” Experience in the Immuno-Gene Therapy Factory of Romagna Cancer Center 89
Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience 85
Circulating memory B-cell receptor repertoire analysis identifies novel candidate antibodies against metastatic melanoma in immunotherapy-responsive patients 85
Malignant Pleural Mesothelioma: State-of-the-Art on Current Therapies and Promises for the Future 85
Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases 84
Neoadjuvant plus adjuvant combined or sequenced vemurafenib, cobimetinib and atezolizumab in patients with high-risk, resectable BRAF-mutated and wild-type melanoma: NEO-TIM, a phase II randomized non-comparative study 83
Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: A multicenter prospective trial 83
Chlamydia infection and lymphomas: Association beyond ocular adnexal lymphomas highlighted by multiple detection methods 82
Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study 81
Italian nivolumab Expanded Access Programme in melanoma adjuvant setting: patient outcomes and safety profile 81
First-line, Fixed-Duration Nivolumab plus Ipilimumab Followed by Nivolumab in Clinically Diverse Patient Populations With Unresectable Stage III or IV Melanoma: CheckMate 401 80
Activation of infiltrating cytotoxic T lymphocytes and lymphoma cell apoptotic rates in gastric MALT lymphomas - Differences between high-grade and low-grade cases 79
First report of efficacy and safety from the phase II study SECOMBIT (SEquential COMBo Immuno and Targeted Therapy study) 78
Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: Final data 77
CTLA-4 gene variant -1661A>G may predict the onset of endocrine adverse events in metastatic melanoma patients treated with ipilimumab 77
Dabrafenib-trametinib combination in 'field-practice': an Italian experience 76
Appropriate use of tumour biomarkers for treatment with innovative drugs: A retrospective study 74
Dendritic cell-based vaccine in advanced melanoma: update of clinical outcome 72
Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma 72
Radiotherapy and High-Dose Interleukin-2: Clinical and Immunological Results of a Proof of Principle Study in Metastatic Melanoma and Renal Cell Carcinoma 72
High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability 71
Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy 70
Melanoma metastasis mimicking gastric cancer: a challenge that starts from diagnosis 70
Correspondence re: Samowitz et al., Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol. Biomark. Prev., 10 : 917-923, 2001 70
ILLUMINATE 301: A randomized phase III study of tilsotolimod in combination with ipilimumab compared with ipilimumab alone in patients with advanced melanoma following progression on or after anti-PD-1 therapy 69
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma 68
Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: clinical and immunological evidence from three patient cases 59
Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4(+)CD25(++)Foxp3(+) regulatory T-cells in advanced melanoma patients 57
Changes in AXL and/or MITF melanoma subpopulations in patients receiving immunotherapy 52
Adjuvant dendritic cell-based immunotherapy in melanoma: insights into immune cell dynamics and clinical evidence from a phase II trial 51
Randomized, Open-Label, Phase III Study of Tilsotolimod in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced Refractory Melanoma (ILLUMINATE-301) 51
Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: evaluation of biomarkers of immunologic and therapeutic response 50
IGKV3 Proteins as Candidate "Off-the-Shelf" Vaccines for Kappa-Light Chain-Restricted B-Cell Non-Hodgkin Lymphomas 50
Melanoma vaccines in development 49
Retinoic acid inhibits IL-6-dependent but not constitutive STAT3 activation in Epstein-Barr virus-immortalized B lymphocytes 48
Sequencing of Checkpoint or BRAF/MEK Inhibitors on Brain Metastases in Melanoma 45
Interleukin-10 and interleukin-18 promoter polymorphisms in an Italian cohort of patients with undifferentiated carcinoma of nasopharyngeal type 42
First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax) 40
Retinoic acid stabilizes p27(Kip1) in EBV-immortalized lymphoblastoid B cell lines through enhanced proteasome-dependent degradation of the p45(Skp2) and Cks1 proteins 40
Rituximab in patients with mucosal-associated lymphold tissue-type lymphoma of the ocular adnexa 39
Isolated bone marrow manifestation of HIV-associated Hodgkin lymphoma 39
Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas 39
High serum levels of soluble CD40-L in patients with undifferentiated nasopharyngeal carcinoma: pathogenic and clinical relevance 38
Tenth annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), SIENA, Italy, November 5-7, 2012 38
IDIOTYPIC VACCIN 38
Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study 37
Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma 37
Undifferentiated nasopharyngeal carcinoma from a nonendemic area: Protective role of HLA allele products presenting conserved EBV epitopes 36
Liver Metastases from Melanoma: Hepatic Intra-Arterial Chemotherapy. A Retrospective Study 36
Ipilimumab in advanced melanoma: reports of long-lasting responses 35
Unexpected High Response Rate to Traditional Therapy after Dendritic Cell-Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis 33
Diagnostic accuracy of 18F-FDG PET/CT in muscle-invasive bladder cancer: rationale and design of the MIBC-PET study 32
Vaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and/or preleukapheresis IFN-alpha in patients with metastatic melanoma: a randomised "proof-of-principle" phase II study 32
Increased frequency of acute reactions to iodinated contrast media in cancer patients treated with anti-CTLA-4 immunomodulatory antibodies. 32
Epigenetic remodelling of DNA in cancer 28
Infectious agents in mucosa-associated lymphoid tissue-type lymphomas: Pathogenic role and therapeutic perspectives 28
IL-17/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemia 27
MicroRNAs and dendritic cell-based vaccination in melanoma patients 23
Latent membrane protein 1 deletion mutants accumulate in Reed-Sternberg cells of human immunodeficiency virus-related Hodgkin's lymphoma 21
Skewing effect of sulprostone on dendritic cell maturation compared with dinoprostone 19
Totale 6.635
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.499
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 281
Totale 35.780
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202249 0 0 1 2 1 2 1 9 3 4 3 23
2022/202351 6 4 1 4 9 4 1 3 8 1 8 2
2023/2024197 3 6 3 2 0 50 0 51 0 4 19 59
2024/20251.281 38 105 69 7 189 166 31 41 192 206 133 104
2025/20264.148 269 109 272 415 526 209 451 217 417 509 408 346
2026/2027642 205 221 216 0 0 0 0 0 0 0 0 0
Totale 6.635